721 Electrophilic Nitro-Fatty Acids Suppress Psoriasiform Dermatitis Through the Inhibition of NF-κB and STAT3

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.03.797
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Electrophilic Nitro-Fatty Acids Suppress Allergic Contact Dermatitis in Mice

Allergy: European Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Unsaturated Fatty Acids Regulate Stemness of Ovarian Cancer Cells Through NF-κB

Stem Cell Investigation
2017English

Polyunsaturated Fatty Acids Suppress Glycolytic and Lipogenic Genes Through the Inhibition of ChREBP Nuclear Protein Translocation

Journal of Clinical Investigation
Medicine
2005English

STAT3 Speeds Up Progression of Osteoarthritis Through NF‑κB Signaling Pathway

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Ghrelin Protects Against Contact Dermatitis and Psoriasiform Skin Inflammation by Antagonizing TNF-α/NF-κB Signaling Pathways

Scientific Reports
Multidisciplinary
2019English

Inhibition of NF-κB Signaling Retards Eosinophilic Dermatitis in SHARPIN-Deficient Mice

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2011English

Omega 3 Polyunsaturated Fatty Acids Suppress the Development of Aortic Aneurysms Through the Inhibition of Macrophage-Mediated Inflammation

Circulation Journal
MedicineCardiovascular MedicineCardiology
2015English

Renoprotective Effects of Ursolic Acid on Ischemia/Reperfusion-Induced Acute Kidney Injury Through Oxidative Stress, Inflammation and the Inhibition of STAT3 and NF-κB Activities

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Gynostemma Pentaphyllum Saponins Attenuate Inflammation in Vitro and in Vivo by Inhibition of NF-κB and STAT3 Signaling

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy